Lexaria Bioscience Corp Stock Shares Outstanding
Lexaria Bioscience Corp fundamentals help investors to digest information that contributes to Lexaria Bioscience's financial success or failures. It also enables traders to predict the movement of Lexaria OTC Stock. The fundamental analysis module provides a way to measure Lexaria Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lexaria Bioscience otc stock.
Lexaria |
Lexaria Bioscience Corp OTC Stock Shares Outstanding Analysis
Lexaria Bioscience's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Lexaria Bioscience Shares Outstanding | 89.59 M |
Most of Lexaria Bioscience's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lexaria Bioscience Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Lexaria Bioscience Corp has 89.59 M of shares currently outstending. This is 78.48% lower than that of the Consumer Defensive sector and 65.43% lower than that of the Packaged Foods industry. The shares outstanding for all United States stocks is 84.33% higher than that of the company.
Lexaria Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lexaria Bioscience's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Lexaria Bioscience could also be used in its relative valuation, which is a method of valuing Lexaria Bioscience by comparing valuation metrics of similar companies.Lexaria Bioscience is currently under evaluation in shares outstanding category among related companies.
Lexaria Fundamentals
| Return On Equity | -164.27 | |||
| Return On Asset | -87.72 | |||
| Current Valuation | 21.27 M | |||
| Shares Outstanding | 89.59 M | |||
| Shares Owned By Insiders | 0.60 % | |||
| Shares Owned By Institutions | 0.11 % | |||
| Price To Earning | (13.00) X | |||
| Price To Book | 8.99 X | |||
| Price To Sales | 48.33 X | |||
| Revenue | 384.54 K | |||
| Gross Profit | 276.93 K | |||
| EBITDA | (3.75 M) | |||
| Net Income | (3.93 M) | |||
| Cash And Equivalents | 1.31 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 156.1 K | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 8.52 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (2.66 M) | |||
| Earnings Per Share | (0.05) X | |||
| Beta | 2.12 | |||
| Market Capitalization | 18.58 M | |||
| Total Asset | 331 K | |||
| Retained Earnings | (10.99 M) | |||
| Working Capital | (53 K) | |||
| Current Asset | 279 K | |||
| Current Liabilities | 332 K | |||
| Z Score | -10.1 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Lexaria OTC Stock
If you are still planning to invest in Lexaria Bioscience Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lexaria Bioscience's history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |